Report: Canadian biotechs heading for "significant consolidation"

Ernst & Young, which reported on the U.S. biotechnology industry outlook earlier this week, also looked at the Canadian industry and said it expects "significant industry consolidation" to take place this year. The Canadian industry lags behind its U.S. counterparts because it is dominated by small, undercapitalized firms, which nevertheless posted a 21% gain in revenues in 2004 over the previous year.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC